TG Therapeutics (TGTX) Competitors $37.09 +0.38 (+1.04%) As of 12:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TGTX vs. TEVA, GMAB, SMMT, RDY, ASND, VTRS, ROIV, QGEN, ELAN, and BBIOShould you be buying TG Therapeutics stock or one of its competitors? The main competitors of TG Therapeutics include Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Viatris (VTRS), Roivant Sciences (ROIV), QIAGEN (QGEN), Elanco Animal Health (ELAN), and BridgeBio Pharma (BBIO). These companies are all part of the "pharmaceutical products" industry. TG Therapeutics vs. Its Competitors Teva Pharmaceutical Industries Genmab A/S Summit Therapeutics Dr. Reddy's Laboratories Ascendis Pharma A/S Viatris Roivant Sciences QIAGEN Elanco Animal Health BridgeBio Pharma Teva Pharmaceutical Industries (NYSE:TEVA) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment. Does the media prefer TEVA or TGTX? In the previous week, Teva Pharmaceutical Industries had 14 more articles in the media than TG Therapeutics. MarketBeat recorded 16 mentions for Teva Pharmaceutical Industries and 2 mentions for TG Therapeutics. TG Therapeutics' average media sentiment score of 0.92 beat Teva Pharmaceutical Industries' score of 0.82 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive TG Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TEVA or TGTX more profitable? TG Therapeutics has a net margin of 13.31% compared to Teva Pharmaceutical Industries' net margin of -0.95%. Teva Pharmaceutical Industries' return on equity of 46.10% beat TG Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-0.95% 46.10% 7.18% TG Therapeutics 13.31%26.05%9.58% Do analysts prefer TEVA or TGTX? Teva Pharmaceutical Industries presently has a consensus target price of $25.57, suggesting a potential upside of 27.57%. TG Therapeutics has a consensus target price of $49.00, suggesting a potential upside of 32.11%. Given TG Therapeutics' higher probable upside, analysts clearly believe TG Therapeutics is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00TG Therapeutics 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility and risk, TEVA or TGTX? Teva Pharmaceutical Industries has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500. Do institutionals and insiders hold more shares of TEVA or TGTX? 54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by company insiders. Comparatively, 10.6% of TG Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings & valuation, TEVA or TGTX? TG Therapeutics has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.54B1.39-$1.64B-$0.16-125.28TG Therapeutics$329M17.89$23.38M$0.37100.24 SummaryTG Therapeutics beats Teva Pharmaceutical Industries on 11 of the 17 factors compared between the two stocks. Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TGTX vs. The Competition Export to ExcelMetricTG TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.89B$3.35B$6.13B$10.62BDividend YieldN/A2.28%5.66%4.70%P/E Ratio100.2422.1385.9727.20Price / Sales17.89267.29531.49204.35Price / Cash305.9746.3226.3031.12Price / Book25.949.9712.726.67Net Income$23.38M-$52.35M$3.30B$276.04M7 Day Performance0.71%6.25%4.30%3.16%1 Month Performance15.15%11.93%7.58%10.56%1 Year Performance66.85%25.16%73.65%33.67% TG Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TGTXTG Therapeutics4.4671 of 5 stars$37.09+1.0%$49.00+32.1%+65.1%$5.89B$329M100.24290Analyst ForecastTEVATeva Pharmaceutical Industries3.1703 of 5 stars$19.17+4.5%$25.14+31.2%+14.4%$21.04B$16.54B-119.8136,830Analyst ForecastGMABGenmab A/S4.1388 of 5 stars$29.33+0.9%$40.00+36.4%+42.9%$18.65B$3.12B14.742,682High Trading VolumeSMMTSummit Therapeutics3.0487 of 5 stars$21.16+1.0%$31.29+47.9%+12.3%$15.56B$700K-20.95110RDYDr. Reddy's Laboratories3.2606 of 5 stars$13.96-1.9%$16.95+21.5%-9.5%$11.87B$3.81B21.1427,811Positive NewsASNDAscendis Pharma A/S3.2716 of 5 stars$191.60-0.2%$244.36+27.5%+43.0%$11.83B$393.54M-37.131,017VTRSViatris1.1631 of 5 stars$9.62+1.1%$10.40+8.1%-12.1%$11.10B$14.74B-3.3232,000ROIVRoivant Sciences3.4279 of 5 stars$15.10-0.5%$19.94+32.0%+42.1%$10.36B$29.05M-21.57860QGENQIAGEN4.4621 of 5 stars$43.880.0%$49.69+13.2%+10.5%$9.76B$1.98B25.935,765Analyst DowngradeELANElanco Animal Health2.5065 of 5 stars$19.63+0.1%$18.33-6.6%+40.8%$9.74B$4.44B22.829,000BBIOBridgeBio Pharma4.1948 of 5 stars$51.96+3.8%$63.94+23.1%+109.5%$9.57B$221.90M-12.70400 Related Companies and Tools Related Companies Teva Pharmaceutical Industries Alternatives Genmab A/S Alternatives Summit Therapeutics Alternatives Dr. Reddy's Laboratories Alternatives Ascendis Pharma A/S Alternatives Viatris Alternatives Roivant Sciences Alternatives QIAGEN Alternatives Elanco Animal Health Alternatives BridgeBio Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TGTX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
